Genomic AI / Variant Effect PredictionResearch API4.9 / 5.0 (编辑评审认证)

AlphaGenome

Unified Deep Learning for Non-Coding Variant Effects & Epigenetic Predictions

Google DeepMind's frontier AI model mapping genetic variations directly to molecular phenotypes across cell types and tissues.

Developed by:Google DeepMind
#Variant Effect#Deep Learning#Epigenetics#RNA-seq#ChIP-seq#Non-coding DNA#DeepMind
访问官方平台阅读 Nature/学术论文
✓ Free Web Access • Safe & Verified

技术架构与背景概述

AlphaGenome is a breakthrough deep learning model from Google DeepMind engineered to decode the 98% non-coding genome. While traditional variant effect predictors rely on evolutionary conservation or hand-engineered biochemical annotations, AlphaGenome models regulatory DNA sequence-to-function end-to-end. Given a raw DNA sequence or a genomic variant (SNV/Indel), it predicts changes in gene expression (RNA-seq), chromatin accessibility (DNase/ATAC-seq), histone modifications (ChIP-seq), and transcription factor binding profiles across hundreds of human cell lines and tissues.

攻克的核心生物学挑战

Over 90% of disease-associated variants identified by Genome-Wide Association Studies (GWAS) reside in non-coding regulatory elements (promoters, enhancers, silencers). Discerning true causal variants from passenger linkage disequilibrium (LD) blocks and predicting their quantitative effect on downstream gene expression has long been a key bottleneck in translational genomics.

核心能力与技术亮点

1

Single-Nucleotide Sensitivity in 1Mb Context

Processes up to 1 million base pairs of surrounding genomic sequence, capturing long-range enhancer-promoter looping interactions that dictate gene transcription.

2

Multi-Modal Epigenetic Predictions

Simultaneously predicts RNA-seq abundance, DNase-I hypersensitive sites, and active histone marks (H3K27ac, H3K4me3) in a unified tensor representation.

3

Tissue & Cell-Type Specificity

Distinguishes cell-type specific regulatory wiring, such as hepatocytes vs. T-cells, enabling precise interpretation of tissue-restricted autoimmune or metabolic traits.

4

Saturation Mutagenesis Scanning

Capable of in silico in-silico saturation mutagenesis (ISM), scanning every single base in a locus to build predictive regulatory maps.

实战调用命令与代码示例

Query AlphaGenome using 1-based genomic coordinates (chr:pos:ref>alt) on GRCh38 to compute tissue-specific variant disruption:

python
terminal - bio_query_alphagenome.py
import requests
import json

# Define the target genomic variant (e.g. non-coding regulatory SNP)
# Coordinate format: chr:pos:ref>alt in GRCh38
variant_id = "chr7:117559590:A>G"

payload = {
    "variant": variant_id,
    "genome_build": "GRCh38",
    "target_assays": ["RNA-seq", "DNASE", "H3K27ac"],
    "tissues": ["lung_epithelium", "whole_blood", "liver"],
    "window_size_bp": 100000
}

response = requests.post(
    "https://api.alphagenome.org/v1/predict_variant",
    headers={"Authorization": "Bearer YOUR_RESEARCH_API_KEY"},
    json=payload
)

predictions = response.json()
print("Predicted expression log2FC:", predictions["gene_effects"][0]["log2_fold_change"])

输入参数与模型输出数据看板

输入格式
Genomic Coordinate (1-based GRCh38)
chr7:117559590:A>G
Reference Allele: A
Alternate Allele: G
Locus: CFTR upstream enhancer region

Input specifies the chromosome, nucleotide position, reference base, and observed alternate allele.

模型返回结果
JSON Output
{
  "variant": "chr7:117559590:A>G",
  "summary_score": 0.884,
  "significance_tier": "High Regulatory Impact",
  "gene_effects": [
    {
      "gene_symbol": "CFTR",
      "ensembl_id": "ENSG00000001626",
      "tissue": "lung_epithelium",
      "log2_fold_change": -1.42,
      "p_value": 0.00018,
      "motif_disrupted": "FOXA1_pioneer_factor"
    },
    {
      "gene_symbol": "CFTR",
      "tissue": "whole_blood",
      "log2_fold_change": -0.04,
      "p_value": 0.62,
      "motif_disrupted": "none"
    }
  ],
  "epigenetics": {
    "chromatin_accessibility_delta": -0.68,
    "H3K27ac_signal_delta": -0.81
  }
}

数值经归一化处理,直接对应下游生物表型预测。

预测结果生物学解读指南

科研人员如何理解预测数值、判别致病阈值与分子调控机制:

log2_fold_change < -1.0
Significant Downregulation (>50% decrease in mRNA expression)

Indicates the alternate allele disrupts a critical positive transcription factor binding motif in the enhancer, drastically attenuating target gene transcription.

Chromatin Accessibility Delta < -0.5
Enhancer Silencing / Chromatin Compaction

The variant transitions the chromatin state from open (accessible to RNA Pol II and pioneer factors) to nucleosome-dense/closed chromatin.

Tissue Selectivity (Lung vs. Whole Blood)
Strict Cell-Type Specific Phenotype

Because FOXA1 pioneer activity is lung-epithelial specific, the variant exerts zero effect in whole blood cells, explaining why patient blood transcriptomes appear normal.

AlphaGenome vs. 传统分析工具横向对比

对比维度AlphaGenome (This Tool)传统方法
Input ModalityRaw DNA sequence (up to 1Mb context)Conservation scores (PhyloP, PhastCons) + Overlap beds
Expression EffectPredicts directional log2 fold change per tissueBinary score or rank (pathogenic / benign)
Long-Range EnhancersFully modeled via attention transformerProximal promoter biases, blind to distal loops
Cell-type SpecificityHundreds of specific human tissues/cellsStatic pan-human metric (e.g. CADD score)

常见问题与专家解答 (FAQ)

What is AlphaGenome and how does it differ from AlphaFold?

While AlphaFold predicts the 3D atomic structure of folded proteins from amino acid sequences, AlphaGenome operates on DNA regulatory sequences to predict gene transcription, epigenetic signals, and non-coding variant consequences.

What genomic coordinate format does AlphaGenome require?

AlphaGenome standardly uses 1-based GRCh38 coordinates in the format `chr[N]:[pos]:[ref]>[alt]`. It also accepts raw FASTA sequences for synthetic promoter and enhancer engineering.

Can AlphaGenome prioritize non-coding GWAS hits?

Yes, fine-mapping GWAS loci is a primary use case. By scoring all variants within an LD block, AlphaGenome highlights which specific nucleotide substitution causes functional transcriptional disruption.